Parcion Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.03M Hold
12,871
– – 0.11% 118
2026
Q2
$2.04M Buy
12,871
+17
+0.1% +$2.3K 0.11% 116
2026
Q1
$1.64M Hold
12,854
– – 0.1% 121
2025
Q4
$1.57M Sell
12,854
-5,845
-31% -$670K 0.1% 113
2025
Q3
$1.87M Sell
18,699
-3,196
-15% -$288K 0.12% 101
2025
Q2
$1.82M Hold
21,895
– – 0.13% 96
2025
Q1
$1.78M Hold
21,895
– – 0.14% 92
2024
Q4
$1.97M Sell
21,895
-4,033
-16% -$391K 0.15% 85
2024
Q3
$2.56M Hold
25,928
– – 0.21% 75
2024
Q2
$2.4M Sell
25,928
-658
-2% -$59K 0.22% 77
2024
Q1
$2.52M Buy
+26,586
New +$2.47M 0.22% 79

Other funds holding XBI

Parcion Private Wealth's XBI Position: Q3 2026 in Review

Parcion Private Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 12,871 shares worth $2.03M. The position accounts for 0.11% of the portfolio, ranked #118.

Parcion Private Wealth first reported a position in XBI in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.56M in Q3 2024. 961 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Parcion Private Wealth held 12,871 shares of State Street SPDR S&P Biotech ETF worth $2.03M as of Q3 2026.
  • Parcion Private Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.11% of Parcion Private Wealth's portfolio in Q3 2026, its #118 holding.
  • Parcion Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 11 quarters since.
  • Parcion Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $2.56M in Q3 2024.
  • 961 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Parcion Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.